MOH News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

MO

Mkt Cap

$10.82B

Volume

541.23K

Next Earnings

October 21st

Loading chart

MO

MOHMolina Healthcare, Inc.

MOH

Pay with—

Available Balance0.00

MO

Mkt Cap

$11.09B

Volume

541.23K

Next Earnings

October 21st

Chart Financials Earnings News About Insider Filings

UnitedHealth's Q3 Margins Improve, But Membership Falls: Time to Buy?UnitedHealth Group reported Q3 adjusted earnings of $4.69 per share, beating estimates by 13.9% with a 60.6% year-over-year increase. The company raised its 2026 EPS outlook to at least $20.50, driven by improved margins and lower medical costs. However, membership declined to 48.3 million from 50.1 million, raising questions about long-term sustainability. Optum also showed strong recovery with margins expanding to 5.6%. The stock carries a Zacks Rank #2 (Buy) rating with valuation below historical medians.Zacks Investment Research · Oct 16, 2026

Can Molina Healthcare Overcome Lower Premiums and Higher MCR in Q3?Molina Healthcare is projected to report a 60.9% earnings decline in Q3 2026 with revenues falling 4.8%. The company faces multiple headwinds including a 12.7% membership decline (63% drop in Marketplace enrollment), rising medical care ratio to 93%, and falling premium revenues and investment income. The stock has a negative Earnings ESP of -3.30% and Zacks Rank #4 (Sell), making an earnings beat unlikely.Zacks Investment Research · Oct 16, 2026

Oscar Health vs. Molina: Which Healthcare Stock Is a Better Buy?Oscar Health (OSCR) is positioned as the stronger investment compared to Molina Healthcare (MOH), driven by robust 46% membership growth, 70% revenue increase, a 20% revenue CAGR target through 2027, and a lower valuation multiple. Molina faces headwinds from rising medical costs, enrollment challenges, and portfolio restructuring, with a projected 2027 exit from its MAPD business and $1 billion marketplace premium reduction.Zacks Investment Research · Oct 16, 2026

Analysts Estimate Molina (MOH) to Report a Decline in Earnings: What to Look Out forMolina Healthcare is expected to report a significant year-over-year earnings decline of 60.9% to $0.72 per share for Q3 2026, with revenues down 4.8% to $10.93 billion. The stock carries a Zacks Rank #4 (Sell) with a negative Earnings ESP of -3.30%, making it unlikely to beat consensus estimates. While the company has beaten estimates in 2 of the last 4 quarters, current analyst sentiment has turned bearish with recent estimate revisions.Zacks Investment Research · Oct 14, 2026

Centene vs. Molina: Which Managed Care Stock Has More Upside?Centene (CNC) and Molina Healthcare (MOH) are compared as major players in U.S. managed care with significant Medicaid exposure. Centene benefits from diversified operations across Medicaid, Medicare, and Marketplace plans, improving margins, and strong financial position with lower leverage. Molina faces near-term profitability pressures from reimbursement challenges and Marketplace headwinds, though its expanding Medicaid contracts and Medicare Duals strategy offer long-term growth. Analysts favor Centene for near-term upside based on stronger earnings estimates, valuation, and recent stock performance.Zacks Investment Research · Oct 12, 2026

Can Oscar Health Turn ACA Marketplace Growth Into Lasting Profits?Oscar Health (OSCR) has surged 130% year-to-date driven by ACA marketplace expansion and plans to enter 150+ metro areas by 2027. However, the stock trades at a premium 4.94 price-to-book ratio versus the industry average of 2.64, and long-term profitability depends on disciplined underwriting and cost management rather than favorable policy conditions alone. Concentration risk from ACA exposure and potential subsidy policy changes pose headwinds.Zacks Investment Research · Oct 8, 2026

UnitedHealth Gears Up for Q3 Earnings: Should Investors Buy the Stock?UnitedHealth Group is expected to report Q3 2026 earnings on October 13, 2026, with projected EPS growth of 41.1% to $4.12 per share, despite a 1.6% revenue decline to $111.38 billion. The company faces headwinds from declining memberships across commercial, Medicare Advantage, and Medicaid segments, but improved medical cost management and operational restructuring are expected to support margin expansion. UnitedHealth trades below its historical valuation median at 17.15X forward earnings, positioning it for potential recovery.Zacks Investment Research · Oct 8, 2026

Oscar Health Trading at a Premium: Why Should You Still Buy It?Oscar Health (OSCR) trades at a premium valuation of 4.65x book value but has gained 142.5% year-to-date, driven by strong membership growth to 2.96 million, 70% revenue surge to $4.88 billion in Q2, and improved profitability. The company targets 20% revenue CAGR through 2027 and 5% operating margin next year, supported by its technology-driven platform and expansion into 150+ new metropolitan areas. Analysts maintain optimistic sentiment with upward earnings estimate revisions.Zacks Investment Research · Oct 5, 2026

UNH vs. MOH: Which Managed Care Stock Looks More Attractive?UnitedHealth Group (UNH) and Molina Healthcare (MOH) are compared as investment options in the managed care sector. UNH benefits from diversification through its Optum platform, improving profitability, and a stronger balance sheet, but faces membership pressure. MOH offers a focused recovery story with stabilizing Medicaid economics and growth in Medicare dual-eligible plans, commanding a higher valuation. Despite UNH's operational strengths, MOH is rated as the more attractive investment due to stronger projected earnings rebound, earning a Zacks Rank #1 (Strong Buy) versus UNH's Rank #2 (Buy).Zacks Investment Research · Sep 23, 2026

How Centene's Strong Cash Flow Is Reshaping Its Balance SheetCentene Corporation has significantly improved its financial position by generating nearly $8 billion in operating cash flow in the first half of 2026 and reducing its debt-to-capital ratio to 41.6% through $1.3 billion in senior note repurchases. The company monetized $1 billion in Part D receivables to support debt reduction while maintaining financial flexibility amid Medicaid payment timing swings.Zacks Investment Research · Sep 22, 2026

to start trading

MO

MOHMolina Healthcare, Inc.

MOH

Pay with—

Available Balance0.00

Your PositionYou don't own any MOH yet.

Related Tickers

Earnings